JMP Securities analyst Roy Buchanan reiterated a Buy rating on Arbutus Biopharma (ABUS – Research Report) today and set a price target of $5.00. Don't Miss our Black Friday Offers: Roy Buchanan has ...
Inovio Pharmaceuticals (INO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Roy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback